Gene signature‐based prediction of triple‐negative breast cancer patient response to Neoadjuvant chemotherapy is a research paper published in Cancer Medicine (2020). On theSindex it has a DataRank of 0.542. It has been cited 36 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.542
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 1R01CA547195
National Institutes of Health
Grant: UL1TR001086
NCI NIH HHS
Grant: R21 CA227996
National Institutes of Health
Grant: 5UL1TR001086-03
SYNERGY: The Dartmouth Center for clinical and Translational Science
National Institutes of Health
Grant: 5R21CA227996-02
Computational Identification of new candidate drugs for lung cancer treatment
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals